Every Form 4 that BlackRock Science and Technology Term Trust (BSTZ) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BSTZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BSTZ filings page.
BlackRock Science & Technology Term Trust vice president Stephen Thomas Minar reported buying additional common shares of BSTZ. On February 10, 2026, he made several open‑market purchases at prices around $23.15 per share, including trades at $23.08 and $23.14.
After these transactions, Minar directly owned 8,074.209 shares of the trust’s common stock, indicating increased personal exposure to the fund.
BlackRock Science & Technology Term Trust portfolio manager Tony Kim reported buying additional common shares of BSTZ. On February 5, 2026, he purchased 41,525 shares at $22 per share and 300 shares at $21.96 per share. The filing shows directly owned positions of 251,554.3651 and 210,029.3651 common shares following the respective transactions.
BlackRock Science & Technology Term Trust (BSTZ) portfolio manager Tony Kim reported a mix of phantom share awards, conversions and a stock sale. On January 30, 2026, he received 20,534.0483 phantom shares, each economically equivalent to one common share and payable in cash as they vest over three years.
On the same date, 9,845.5493 and 5,734.6195 phantom shares were converted into the same number of common shares. Kim then sold 15,580.1688 common shares at $22.38 per share, leaving him with 208,712 common shares held directly after the sale.
BlackRock Science & Technology Term Trust reported an insider stock sale by one of its directors. The reporting person sold 9,293 shares of common stock on 12/18/2025 at a price of $22.51 per share. On 12/19/2025, the same person reported an additional sale of 0.6469 shares at $22.73 per share. After these transactions, the filing shows the director beneficially owning 0 shares of the trust’s common stock in direct ownership.